Triple Therapy Improves COPD Outcomes, Regardless of Exacerbation History Clinical Advisor, 10 Mar 2021 Triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered-dose inhaler (BGF MDI) in patients with chronic…